These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


659 related items for PubMed ID: 8585430

  • 1. Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: a dual-energy X-ray absorptiometric and histomorphometric study.
    Chen HK, Ke HZ, Jee WS, Ma YF, Pirie CM, Simmons HA, Thompson DD.
    J Bone Miner Res; 1995 Aug; 10(8):1256-62. PubMed ID: 8585430
    [Abstract] [Full Text] [Related]

  • 2. Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.
    Ke HZ, Simmons HA, Pirie CM, Crawford DT, Thompson DD.
    Endocrinology; 1995 Jun; 136(6):2435-41. PubMed ID: 7750465
    [Abstract] [Full Text] [Related]

  • 3. Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model.
    Ke HZ, Chen HK, Simmons HA, Qi H, Crawford DT, Pirie CM, Chidsey-Frink KL, Ma YF, Jee WS, Thompson DD.
    Bone; 1997 Jan; 20(1):31-9. PubMed ID: 8988345
    [Abstract] [Full Text] [Related]

  • 4. Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats.
    Ke HZ, Chen HK, Qi H, Pirie CM, Simmons HA, Ma YF, Jee WS, Thompson DD.
    Bone; 1995 Nov; 17(5):491-6. PubMed ID: 8579962
    [Abstract] [Full Text] [Related]

  • 5. Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized rats.
    Ke HZ, Crawford DT, Qi H, Pirie CM, Simmons HA, Chidsey-Frink KL, Chen HK, Jee WS, Thompson DD.
    Bone; 1999 Jan; 24(1):41-7. PubMed ID: 9916783
    [Abstract] [Full Text] [Related]

  • 6. Dual-energy x-ray absorptiometry of raloxifene effects on the lumbar vertebrae and femora of ovariectomized rats.
    Sato M, McClintock C, Kim J, Turner CH, Bryant HU, Magee D, Slemenda CW.
    J Bone Miner Res; 1994 May; 9(5):715-24. PubMed ID: 8053401
    [Abstract] [Full Text] [Related]

  • 7. An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats.
    Marie PJ, Hott M, Modrowski D, De Pollak C, Guillemain J, Deloffre P, Tsouderos Y.
    J Bone Miner Res; 1993 May; 8(5):607-15. PubMed ID: 8511988
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The effect of orally administered clodronate on bone mineral density and bone geometry in ovariectomized rats.
    Osterman T, Laurén L, Kuurtamo P, Hannuniemi R, Isaksson P, Kippo K, Peng Z, Väänänen HK, Sellman R.
    J Pharmacol Exp Ther; 1998 Jan; 284(1):312-6. PubMed ID: 9435193
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Estrogen supplementation modulates effects of the endocrine disrupting pollutant PCB126 in rat bone and uterus: diverging effects in ovariectomized and intact animals.
    Lind PM, Eriksen EF, Lind L, Orberg J, Sahlin L.
    Toxicology; 2004 Jul 01; 199(2-3):129-36. PubMed ID: 15147787
    [Abstract] [Full Text] [Related]

  • 14. Long-term zoledronic acid treatment increases bone structure and mechanical strength of long bones of ovariectomized adult rats.
    Hornby SB, Evans GP, Hornby SL, Pataki A, Glatt M, Green JR.
    Calcif Tissue Int; 2003 Apr 01; 72(4):519-27. PubMed ID: 12574877
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Estrogen and "exercise" have a synergistic effect in preventing bone loss in the lumbar vertebra and femoral neck of the ovariectomized rat.
    Li CY, Jee WS, Chen JL, Mo A, Setterberg RB, Su M, Tian XY, Ling YF, Yao W.
    Calcif Tissue Int; 2003 Jan 01; 72(1):42-9. PubMed ID: 12370795
    [Abstract] [Full Text] [Related]

  • 20. High-dose gestagens modulate bone resorption and formation and enhance estrogen-induced endosteal bone formation in the ovariectomized mouse.
    Bain SD, Jensen E, Celino DL, Bailey MC, Lantry MM, Edwards MW.
    J Bone Miner Res; 1993 Feb 01; 8(2):219-30. PubMed ID: 8442440
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 33.